STOCK TITAN
  1. Home
  2. News
  3. BRKR

Bruker Corp - BRKR STOCK NEWS

Welcome to our dedicated news page for Bruker (Ticker: BRKR), a resource for investors and traders seeking the latest updates and insights on Bruker.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Bruker's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Bruker's position in the market.

News
Bruker Announces Date and Time of First Quarter 2024 Earnings Release and Webcast
Rhea-AI Summary
Bruker (BRKR) has announced the date for its first quarter 2024 earnings release and webcast. The financial results will be reported on May 2, 2024, before the market opens. An earnings conference call and webcast will follow at 8:30 a.m. Eastern Time to discuss the results and business trends. Investors can access the webcast through the company's website or by phone. Pre-registration is available for the conference call.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
earnings
-
News
Bruker to Acquire the NanoString Business in an Asset Deal
Rhea-AI Summary
Bruker (BRKR) has entered into a definitive acquisition agreement with NanoString Technologies, Inc., to acquire its business for approximately $392.6 million. The deal includes the acquisition of NanoString's product lines, such as nCounter®, GeoMx®, CosMx™, and AtoMx™. NanoString, a leader in gene expression profiling and spatial transcriptomics, generated revenues of around $168 million in 2023. The acquisition is expected to close in the second quarter of 2024, subject to customary closing conditions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.37%
Tags
acquisition
-
News
Bruker Advances Magnet Technology for Broader Adoption of NMR in Academic and Biopharma Research, and Process Analytical Technologies
Rhea-AI Summary
Bruker introduces novel magnet technology and analytical solutions to promote NMR adoption in research and biopharma industries. The Ascend Evo 600 NMR magnet offers a one-year liquid Helium hold-time, reducing refill intervals and operational costs. Additionally, the Fourier 80 platform with synTQ PAT management software enhances process analysis and quality control in API manufacturing.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.21%
Tags
none
News
Bruker Introduces Novel NMR Scientific Capabilities for Structural Biology Discoveries in Membrane Proteins and Protein Aggregates
Rhea-AI Summary
Bruker introduces novel high-resolution solid-state NMR scientific capabilities at the 65th ENC, enabling structural biology discoveries in large proteins, membrane proteins, and protein aggregates. The new ultra-fast CP/MAS iProbe with 160 kHz MAS system provides enhanced 1H-NMR resolution and T2' times, advancing the study of biological samples. The introduction of standard-bore DNP Probes for 600 and 800 MHz expands solid-state DNP-NMR research accessibility, offering sensitivity enhancements of 50x to 200x.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.21%
Tags
none
-
News
Biognosys and Alamar Biosciences Forge Strategic Partnership in Proteomics to Advance Biopharma and Precision Medicine Research
Rhea-AI Summary
Biognosys and Alamar Biosciences announce a strategic partnership to advance scientific discovery in biofluid proteomics biomarkers. The collaboration combines Biognosys' DIA-MS platform with Alamar's NULISA assays for deep proteomics insights. The partnership will be showcased at the AACR 2024 Annual Meeting with a focus on Non-Small Cell Lung Cancer.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.35%
Tags
partnership
-
News
Bruker Selected as ‘Company of the Year’ by Instrument Business Outlook
Rhea-AI Summary
Bruker (BRKR) has been named the Instrument Business Outlook (IBO) 'Company of the Year' for 2023 due to its impressive double-digit organic revenue growth across all major regions and business groups. The company's innovative model, management processes, and disciplined entrepreneurial culture have led to significant portfolio transformation and sustainable growth. Bruker's strategic initiatives like Project Accelerate 2.0 and Operational Excellence position it as a leader in the post-genomic era, with anticipated strong growth for 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.08%
Tags
none
News
Bruker Advances CCS-Enabled 4D-Proteomics timsTOF Solutions for Immunopeptidomes and Glycoproteomics at US HUPO
Rhea-AI Summary
Bruker Corporation (BRKR) announces advancements in immunopeptidomics, glycoproteomics, and other 4D-proteomics workflows at the 20th US Human Proteome Organization Congress 2024. The company introduces innovative software, methods, and tools to enhance post-genomic research, disease biology insights, and biomarker discovery.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.44%
Tags
none
-
News
Bruker Announces Closing of Chemspeed Technologies AG Acquisition
Rhea-AI Summary
Bruker Corporation (BRKR) successfully closes the acquisition of Chemspeed Technologies AG, a Swiss provider of automated laboratory solutions, marking a significant milestone in Bruker's expansion. The acquisition aligns with Bruker's strategic Project Accelerate 2.0 portfolio transformation, focusing on scientific software, R&D, QC digitalization, and laboratory automation.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.83%
Tags
acquisition
-
News
Bruker Announces Share Purchase Agreement to Acquire Molecular Diagnostics Innovator ELITechGroup
Rhea-AI Summary
Bruker Corporation (BRKR) to Acquire ELITechGroup for €870 Million in Cash, Excluding Clinical Chemistry Business
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.32%
Tags
acquisition
News
Bruker Corporation to Present at Upcoming Investor Conferences
Rhea-AI Summary
Bruker Corporation (BRKR) announces CFO's participation in upcoming investor conferences in New York City and Boston. Webcasts and replays will be available on the company's website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.26%
Tags
conferences
Stock BRKR logo
Bruker Corp

Nasdaq:BRKR

BRKR Rankings

#729 Ranked by Market Cap
#2477 Ranked by Stock Gains
#2065 Ranked by Dividends

BRKR Stock Data

11.55B
89.37M
34.66%
81.89%
2.41%
Analytical Laboratory Instrument Manufacturing
Manufacturing
Link
US
Billerica

About BRKR

right from the beginning, which is now more than fifty years ago, bruker has been driven by a single idea: to provide the best technological solution for each analytical task. today, worldwide, more than 6,500 employees in over 90 locations on all continents are focusing their efforts on this permanent challenge. bruker systems cover a broad spectrum of applications in all fields of research and development and are used in all industrial production processes for the purpose of ensuring quality and process reliability. bruker continues to build upon its extensive range of products and solutions, expand its broad base of installed systems and maintain a strong reputation amongst its customers. as one of the world's leading analytical instrumentation companies, bruker remains focused on developing state-of-the-art technologies and innovative solutions for today’s ever complex analytical questions. bruker - innovation with integrity. bruker corporation company pages bruker axs: https://www